Description

Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. New diagnostic criteria, patient-centered care models, new trends in substance use, research advances on genetics, and much more. It's more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.

That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize assessment, treatment, and management of child and adolescent patients with psychiatric conditions.

  • Meet and engage face-to-face with renowned clinician-researchers who share the latest advances in their fields
  • Find guidance for complex signs and symptoms _ such as emotional outbursts, mood swings, and strange eating habits _ that can be indicative of psychiatric disorders yet can also be part of normal child development
  • Translate the latest research into optimal assessment and treatment strategies for anxiety, substance use disorder, depression, eating disorders, OCD, psychosis, and much more

The American Board of Psychiatry and Neurology has reviewed Child & Adolescent Psychopharmacology 2016 and has approved this program as part of a comprehensive program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Learning Objectives

By the end of this activity, participants should be able to:

  • Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
  • Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
  • Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety.
  • Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
  • Recognize the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.

Agenda

Content and faculty subject to change._

FRIDAY, MARCH 4, 2016

7:00-7:45 am

Registration & Continental Breakfast

7:45-8:00 am

Introduction
Joseph Biederman, MD; Thomas J. Spencer, MD; Timothy E. Wilens, MD

Module Topic: Overview of Pediatric Psychopharmacology

8:00-8:45 am

Diagnosis & Assessment in Pediatric Psychopharmacology
Joseph Biederman, MD

8:45-9:30 am

Preclinical Psychopharmacology: From Mechanisms & Molecules to Medicines
Pradeep G. Bhide, PhD

9:30-9:45 am

Coffee Break

9:45-10:30 am

Implications of Psychiatric Genetics for Psychopharmacology
Roy H. Perlis, MD, MSc

10:30-11:15 am

Panel Discussion
Moderator: Joseph Biederman, MD
Panelists: Pradeep G. Bhide, PhD; Roy H. Perlis, MD, MSc

Module Topic: ADHD

11:15-12:00 pm

ADHD Across the Life Cycle
Joseph Biederman, MD

12:00 pm-1:15 pm

Lunch (on your own)

1:15-2:00 pm

Pharmacologic Treatment of ADHD Across the Life Cycle: Stimulants
Thomas J. Spencer, MD

2:00-2:45 pm

Pharmacologic Treatment of ADHD Across the Life Cycle: Non-Stimulants
Timothy E. Wilens, MD

2:45-3:30 pm

Panel Discussion
Moderator: Joseph Biederman, MD
Panelists: Thomas J. Spencer, MD; Timothy E. Wilens, MD

3:30-3:45 pm

Coffee Break

Module Topic: Substance Use Disorder

3:45-4:30 pm**

Adolescent Substance Use Disorder: From Diagnosis and Treatment to Risk Management and Medico-Legal Concerns**
Timothy E. Wilens, MD

4:30-5:30 pm**

Question and Answer including the Ethical and Safe On- and Off-Label Use of Psychotropics in Practice**
Moderator: Joseph Biederman, MD

Thomas J. Spencer, MD; Timothy E. Wilens, MD; Janet Wozniak, MD

5:30-6:30 pm

Dinner (on your own)

6:30-7:30 pm

Evening Seminars

Participants may choose only one seminar presentation to attend.

1. Management of Substance Abuse in Young People
Amy Yule, MD

2. Managing the Complex Adult with ADHD
Craig Surman, MD

SATURDAY, MARCH 5, 2016

7:30-8:00 am

Continental Breakfast

Module Topic: Mood Disorders

8:00-8:45 am

Juvenile Depression
Karen Wagner, MD, PhD

8:45-9:30 am

Juvenile Mania: Treatment
Janet Wozniak, MD

9:30-9:45 am

Coffee Break

9:45-10:30 am

Differential Unipolar vs. Bipolar Mood Disorders in the Young
Mai Uchida, MD

10:30-11:15 am

Panel Discussion
Moderator: Janet Wozniak, MD
Panelists: Mai Uchida, MD; Karen D. Wagner, MD, PhD

Module Topic:Psychosis, Tourette's, and ASD

11:15-12:00 pm

Managing Pediatric Psychosis including First-Episode
Abigail Donovan, MD

12:00-1:00 pm

Lunch (on your own)

1:00-1:45 pm

Tourette's Disorder & Tics
Barbara J. Coffey, MD, MS

1:45-2:30 pm

Are Autistic Traits Clinically Meaningful?
Joseph Biederman, MD

2:30-3:15 pm

Panel Discussion
Moderator: Joseph Biederman, MD
Panelists: Abigail Donovan, MD, Barbara J. Coffey, MD, MS

3:15-3:30 pm

Coffee Break

Module Topic:Psychological Assessment and Intervention

3:30-4:15 pm

Cognitive Behavioral Treatment in Pediactric Psychiatry
Aude Henin, PhD

4:15-5:00 pm

Neuropsychological Testing
Ronna Fried, EdD

5:00-5:30 pm

Panel Discussion
Moderator: Thomas J. Spencer, MD
Panelists: Aude Henin, PhD; Ronna Fried, EdD

5:30-6:30 pm

Dinner (on your own)

6:30-7:30 pm

Evening Seminars will be presented at 6:30pm. Participants may choose only one seminar presentation to attend.

1. Education Connection
Ronna Fried, EdD

2. Psychiatry in the Primary Care Setting
Andrea E. Spencer, MD

SUNDAY, MARCH 6, 2016

7:00-8:00 am

Continental Breakfast

Module Topic:Neuroimaging and Clinical Topics in Pediatric Psychopharmacology

8:00-8:45 am

Neuroimaging in Clinical Practice
John Gabrieli, PhD

8:45-9:30 am

Pharmacology of Anxiety Disorders and OCD in Childhood and Adolescence
Daniel A. Geller, MD

9:30-10:15 am

PANS-PANDAS
Kyle A. Williams, MD

10:15-11:00 am

Eating Disorders
Kamryn Eddy, PhD

11:00-11:15 am

Coffee Break

11:15-12:00 pm

Parenting at a Difficult Time**
Paula K. Rauch, MD

12:00-12:45 pm

Panel Discussion
Moderator: Daniel A. Geller, MD
Panelists: John Gabrieli, PhD; Kamryn Eddy, PhD; Kyle Williams, MD;Paula K. Rauch, MD

12:45-1:45 pm

Lunch (on your own)

Module Topic: Risk Management Topics

1:45-2:30 pm**

Antidepressants and Suicide Risk and Prevention**
Jefferson B. Prince, MD

2:30-3:15 pm**

Liability Prevention in Child and Adolescent Psychopharmacology**
Ronald Schouten, MD, JD

3:15-4:00 pm**

Pediatric Consultation Liaison: Psychopharmacology in Clinical Practice
Annah N. Abrams, MD

4:00-4:45 pm

Panel Discussion
Moderator: Jefferson B. Prince, MD
Panelists: Ronald Schouten, MD, JD; Annah N. Abrams, MD

4:45 pm

Adjourn

**Sessions are eligible for Risk Management Credit.

Faculty

  • Chief Division of Pediatric Psycho-Oncology, Pediatric Hematology Oncology Unit
    Attending, Child Psychiatry Consultation Liaison Service
    Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Professor, Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience
    Director, Center for Brain Repair, Department of Biomedical Sciences, Florida State University College of Medicine
  • Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD
    Director, Bressler Center for Autism Spectrum Disorder
    Massachusetts General Hospital
    Professor of Psychiatry
    Harvard Medical School
  • Icahn School of Medicine at Mount Sinai
    Professor of Psychiatry
    Chief, Tics and Tourettes Clinical and Research Program
    Research Psychiatrist, Nathan Kline Institute for Psychiatric Research
  • Director, First Episode and Early Psychosis Program
    Associate Director, Acute Psychiatry Service
    Massachusetts General Hospital
  • Co-Director, Eating Disorders Clinical and Research Program, Massachusetts General Hospital
    Assistant Professor Psychiatry, Harvard Medical School
  • Director of Neuropsychology in the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Assistant Professor in Psychology, Harvard Medical School
  • Grover Hermann Professor of Health Sciences and Technology and Cognitive Neuroscience
    Harvard-MIT Division of Health Sciences and Technology (HST) and Department of Brain and Cognitive Sciences
    Massachusetts Institute of Technology
  • Director, Pediatric OCD and Tic Disorder Program, Massachusetts General Hospital
  • Co-Director, Child Cognitive-Behavioral Therapy Program, Department of Psychiatry, Massachusetts General Hospital
  • Associate Director of Addiction Services
  • Director, Center for Experimental Drugs and Diagnostics
    Massachusetts General Hospital
    Associate Professor of Psychiatry
    Harvard Medical School
  • Director of Child Psychiatry, North Shore Medical Center
    Staff, Child Psychiatry and Pediatric Psychopharmacology Clinics, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Director, Family Program, Red Sox Foundation and Massachusetts General Hospital Home Base Program
    Founding Director, Majorie E. Korff PACT (Parenting At a Challenging Time) Program Cancer Center, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Director, Law & Psychiatry Service, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Associate Chief of Psychiatry, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Attending Child Psychiatrist
    Associate Director of Integrated Pediatric Behavioral Health
    Boston Medical Center

    Assistant Professor of Psychiatry
    Boston University School of Medicine
  • Scientific Coordinator, Adult ADHD Research Program, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Staff Psychiatrist, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD
    Lorraine and Alan Bressler Clinical and Research Program for Autism Spectrum Disorders, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Marie B. Gale Centennial Professor & Vice Chair
    Department of Psychiatry & Behavioral Sciences
    Director, Division of Child & Adolescent Psychiatry, University of Texas Medical Branch at Galveston
  • Chief, Division of Child and Adolescent Psychiatry
    Co-Director, Center for Addiction Medicine
    Massachusetts General Hospital
    Associate Professor of Psychiatry
    Harvard Medical School
  • Director, Pediatric Neuropsychiatry and Immunology Program in the OCD and Related Disorders Program
    Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Chair, Quality and Safety Department of Psychiatry
    Director, Child and Adolescent Outpatient Service
    Director, Pediatric Bipolar Disorder Clinical and Research Program
    Massachusetts General Hospital
    Associate Professor of Psychiatry
    Harvard Medical School
  • Assistant in Psychiatry, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School

Target Audience

This program is intended for:

  • Psychiatrists, primary care and family practice physicians, pediatricians, psychologists, nursing professionals, social workers, residents, and other mental health, primary care and pediatric clinicians.

Pricing

MDs/Doctoral-Level Professionals
Early Registration (on or before January 8, 2016): $695.00
Regular Registration (after January 8, 2016): $795.00

Other Professionals or Trainees
Early Registration (on or before January 8, 2016):$595.00
Regular Registration (after January 8, 2016):$695.00

***The deeply discounted Super Early Registration rate is NON-REFUNDABLE and will not be refunded under any circumstances.

Cancellation Policy

Cancellation requests received by February 17, 2016 will receive a full refund minus a $100.00 processing fee. No refunds will be issued after February 17, 2016. Payments made may not be applied toward future conferences or other educational activities. There are no exceptions to these policies. There will be no refunds for those who purchase the deeply discounted Super Early Registration.

Accommodations

Westin Copley Place:

A limited number of rooms have been reserved at the Westin Copley Place.

To reserve online, please click here to open the dedicated booking website for the event.

To reserve by phone, please call 617-262-9600 (local) or 888-627-7216 (international) and specify that you are attending the "2016 Child and Adolescent Psychopharmacology" event.

Marriott Boston Copley Place:

A limited number of rooms have been reserved until February 15, 2016 at Marriott Boston Copley Place.

To reserve by phone, please contact the Marriott and specify that you are attending the "2016 MGH Child and Adolescent Psychopharmacology" event.

Testimonials

Read what past participants say about this conference:

  • Accurate, up-to-date, concise and relevant information effective in clinical practice.
  • Improved my diagnostic skills and treatment approaches to complex patients.
  • Overall, excellent program in terms of clinical and research topics presented, syllabus, and expertise of presenters.
  • I am a primary care pediatrician and I have no doubt that the knowledge and wisdom shared with me at these meetings have directly helped my patients.
  • I really did appreciate that the speakers focused on making the information relevant to practice and not just academic.
  • I think the conference overall was of the highest caliber and I learned a great deal.
  • As always, I found the program extremely informative and critical to ensuring I can deliver the evidenced-based, competent and compassionate care which my families deserve and I strive to provide.
  • I found many take home points that will help improve my care of patients.
  • The program was informative and well done.
  • Very worth my time and money. Thank you.
  • Program was excellent and I will recommend others in our group to take this course in the future.
  • Overall, this was an excellent conference with great information on current research and treatment options. The majority of the presenters were excellent and very informative.
  • This was an exceptional conference and I would recommend it to other providers as well as attend in the future.
  • Excellent program, best child and adolescent psychopharm conference in the country, by far. Thank you.
  • Great program. Really helped increase my confidence in assessing, treating, and monitoring children and adolescents.
  • Excellent program, very well run overall.
  • I have attended this conference in the past and always find it extremely informative and thought provoking.
  • Excellent course.

Scholarships

The Tufnell Park Scholarship Fund, in honor of Robert J. Birnbaum, MD, PhD

We are proud to offer scholarship assistance for mental health and primary care practitioners who demonstrate financial need and a commitment to apply learning to enhance practice.

This exclusive scholarship fund covers full cost of tuition and up to $750 in travel expenses for selected recipients. Applicants must be medical residents and fellows, recent graduates practicing in disadvantaged areas with limited resources, and non-physician professionals including nurses and social workers.

Scholarships are awarded 60 days prior to live conferences and on a rolling basis for online courses.

How To Apply

Please submit your CV and a 300-500 word essay on how a particular conference or online course would help your professional development and your patients. Email this information to mghcme@mgh.harvard.edu.

**Note: Current and former Massachusetts General Hospital employees are not eligible.

For more information, visit mghcme.org/scholarship.

Additional Live Conferences

We offer other live conferences on various facets of mental health in addition to the conference you are currently viewing.
See our full list of mental health conferences.

CME Information

Live Event Date: March 4, 2016 - March 6, 2016

CREDIT

TYPE

ACCREDITATION
STATEMENT

DESIGNATION STATEMENT

25.25

AMA PRACategory
1 Credit
TM

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

McLean Hospital designates this live activity for a maximum of 25.25AMA PRACategory1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

25.25

Psychologists CE Credit

The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 30.75 Continuing Education (CE) credit per presentation for psychologists.

This offering meeting the criteria for 25.25Continuing Education (CE) credits per presentation for psychologists.

25.25

Nursing Contact Hours

Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 25.25 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

25.00

Social Workers

The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

"This program has been approved for 25.00 Social Work Continuing Education hours for
relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College
and Simmons Schools of Social Work Authorization Number D71362.

25.25

self-claim

Other Professions

This course allows other providers to claim a Participation Certificate upon successful completion of this course.

Participation Certificates will specify the title, location, type of activity, date of activity, and number ofAMA PRACategory1 CreditsTMassociated with the activity. Providers should check with their regulatory agencies to determine ways in whichAMA PRACategory1 CreditsTMmay or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.


Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Resolution of Conflict of Interest (COI)

McLean Hospital has implemented a process to resolve COI for each CME activity. In order to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public, McLean Hospital has resolved the conflict by External Content Review.


Planner Disclosures

The MGH Psychiatry Academy adheres to all ACCME Essential Areas, Standards, and Policies. It is the Psychiatry Academy's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that the Psychiatry Academy may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.


Privacy Policy

Please clickhereto review our privacy policy.

Location

The Westin Copley Place, 10 Huntington Avenue, Boston, MA, USA